Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InvestiGAIT Extension: Bimagrumab in Sarcopenia
NCT02468674Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2015
- Primary completion
- Dec 2018
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 2 trial of bimagrumab in Sarcopenia, sponsored by Novartis. Started Jul 2015; status: completed.
02
Drugs
bimagrumab
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT02468674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468674.